ESSEC Business School, Asia-Pacific and Biotech Connection Singapore are organizing a Health, Business and Society (HBS) Talk, “From Clinical Need to Market: Challenges to Commercialization” that will be held in Singapore on the 7th June 2017.
The HBS Public Talk series was initiated with the aim of facilitating and disseminating insights to relevant stakeholders in the industry, so as to deliver meaningful recommendations to both public and private policy decision makers.
Biomedical innovation is poised to become a key pillar of Singapore’s future economy, in areas ranging from biopharmaceuticals, digital health solutions, to diagnostics and medical devices. However, the commercialization of life science technologies is especially long and bumpy, with high chances of failure. How do budding entrepreneurs manage such risks and develop successful go-to-market strategies? How do we prioritize the market segments to focus on, and figure out the best way to engage clinicians and payers?
The talk will explore the perspectives of the experienced panelists, including successful entrepreneurs and industry leaders from public and private sectors.
Date – 7 June 2017
Venue- ESSEC Business School, Asia-Pacific, 5 Nepal Park, Singapore 139408
Limited seats available. Attendance is by pre-registration only.
Dress Code: Business Casual
7:00pm – 7:30pm: Registration and Networking
7:30pm – 9:30pm: Panel discussion and Q&A
Mr. Amkidit AFABLE
Director, Go-to-Market Strategies,
Johnson & Johnson
Mr. David BARDA
Vice President, Medical Technologies Cluster,
Biomedical Sciences Division at Exploit Technologies Pte Ltd
Dr. Snehal PATEL
Mr. Joe CAPUTO
Associate Director, IHEM Asia-Pacific
ESSEC Business School